Collingridge dilemma
The Collingridge dilemma is a concept in the field of technology assessment and ethics.
The Collingridge dilemma is a methodological quandary in the field of technology assessment and ethics, named after the British philosopher David Collingridge. It describes the inherent difficulty in predicting the social consequences of a new technology and the challenges in controlling or altering its development once it has become established.
Overview[edit]
The Collingridge dilemma is articulated in two main propositions:
- The Information Problem: At the early stages of a technology's development, when it is most easily controlled or altered, the full range of its potential impacts cannot be accurately predicted. This is because the technology is not yet fully developed or widely used, and its interactions with society are not well understood.
- The Control Problem: Once a technology becomes entrenched and its effects are more apparent, it becomes difficult and costly to change or regulate. This is due to the technology's integration into social, economic, and political systems, as well as the vested interests that may resist change.
The dilemma highlights the challenges faced by policymakers, ethicists, and technologists in managing the development and deployment of new technologies in a way that maximizes benefits while minimizing harms.
Historical Context[edit]
David Collingridge introduced this concept in his 1980 book, The Social Control of Technology. He argued that traditional methods of technology assessment were inadequate because they failed to account for the dynamic and unpredictable nature of technological innovation.
Implications[edit]
The Collingridge dilemma has significant implications for technology policy and governance. It suggests that:
- Proactive Assessment: There is a need for more proactive and anticipatory approaches to technology assessment that can better account for uncertainty and complexity.
- Flexibility and Adaptability: Policies and regulations should be designed to be flexible and adaptable, allowing for adjustments as more information becomes available.
- Stakeholder Engagement: Engaging a broad range of stakeholders early in the development process can help identify potential impacts and areas of concern.
Criticism and Alternatives[edit]
Some critics argue that the Collingridge dilemma is overly pessimistic and that it underestimates the ability of societies to adapt to technological change. Others propose alternative frameworks, such as the concept of "responsible innovation," which emphasizes the role of ethical reflection and public engagement in guiding technological development.
Also see[edit]
Template:Technology ethics Template:Philosophy of technology
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian